← All LCQ Flashcard Decks

LCQ Research and Evidence Base Flashcards

6 cards from real LCQ practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 LCQ Research and Evidence Base flashcards as text
  1. In what year was the Leicester Cough Questionnaire first published?

    Answer: 2003

    The LCQ was first published in 2003 by Birring et al. in the European Respiratory Journal, establishing its initial validation.

  2. Which journal first published the original LCQ validation study?

    Answer: European Respiratory Journal

    The original LCQ validation study was published in the European Respiratory Journal in 2003.

  3. What was the primary finding of the original LCQ validation study?

    Answer: The LCQ demonstrated good validity, reliability, and responsiveness in chronic cough patients

    The original 2003 validation study confirmed that the LCQ had good construct validity, internal consistency (Cronbach's alpha >0.90), and responsiveness to treatment change.

  4. The MCID of 1.3 points for the LCQ was established through which type of analysis?

    Answer: Anchor-based analysis using patient global ratings of change

    The LCQ MCID of approximately 1.3 points was determined through anchor-based analysis, where patient global impressions of change served as the external anchor.

  5. How many clinical studies had used the LCQ as an outcome measure as of recent literature reviews?

    Answer: Over 100 studies across multiple disease areas

    The LCQ has been used as an outcome measure in over 100 clinical studies spanning COPD, asthma, ILD, and pharmacological and behavioral treatments for chronic cough.

  6. Which study design provides the strongest evidence for the LCQ's responsiveness to treatment?

    Answer: Randomized controlled trials demonstrating score changes following effective treatment

    RCTs that show LCQ scores improve significantly with effective treatment (compared to placebo) provide the strongest evidence of the tool's responsiveness as a clinical outcome measure.